Lexicon Pharmaceuticals
Price & Volume
Stats
See more52W Range | $1-$2.68 |
Market Cap | $986.1M |
Shares Short | 30M |
Financials
See moreRevenue (12 Mos) | $69.6M |
Revenue Growth (YoY) | 1,572.1% |
Gross Profit (12 Mos) | $65.5M |
Diluted EPS | -$0.07 |
News
See moreYahoo Finance • 12 days ago
Lexicon Pharmaceuticals (LXRX) Gains on Russell 3000 Inclusion
Yahoo Finance • 18 days ago
Health Care had the best week vs. the S&P 500 on record
Yahoo Finance • last month
Lexicon Pharmaceuticals vs. Pfizer: Which Drugmaker Stock Is a Better Buy in 2026?
Yahoo Finance • 2 months ago
Citi Raises its Price Target on Lexicon Pharmaceuticals (LXRX)
About
CEO | Dr. Michael S. Exton Ph.D. |
CFO | Mr. Scott M. Coiante |
Address | 2445 Technology Forest Boulevard, The Woodlands, TX, United States, 77381 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 81 |